It might appear shorter
19,20 Additional systematic and scoping reviews have examined the potential role of GLP-1 receptor agonists in the treatment of multiple substance use disorders, but these reviews provide an incomplete review of the existing literature on AUD
office, institutional and telehealth visits at 95
Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted